GMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5

NCT05695508 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Teclistamab (Tec)
DRUG: Daratumumab
DRUG: Dexamethasone
DRUG: Lenalidomide
DRUG: Bortezomib
DRUG: Talquetamab
DRUG: JNJ-79635322

Sponsor

University of Heidelberg Medical Center

Collaborators

[object Object]
[object Object]